We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Name | Symbol | Market | Type |
|---|---|---|---|
| Bayer Aktiengesellschaft (PK) | USOTC:BAYRY | OTCMarkets | Depository Receipt |
| Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.01 | 0.13% | 7.61 | 7.55 | 7.66 | 7.62 | 7.57 | 7.62 | 1,626,365 | 21:01:29 |
From May 2019 to May 2024
By Colin Kellaher
Elanco Animal Health Inc. (ELAN) Thursday said it raised more than $1.3 billion through public equity offerings to help fund its pending $7.6 billion acquisition of Bayer AG's (BAYN.XE) animal-health unit.
The Greenfield, Ind., animal-health company said it priced an upsized offering of about 22.7 million common shares at $32 apiece and an offering of 11 million 5% tangible equity units at $50 each.
Elanco, which had previously planned to sell about 19.2 million common shares, said it expects to complete the offerings Jan. 27.
The company said it has applied to list the tangible equity units on the New York Stock Exchange under the symbol ELAT.
Elanco last year agreed to pay about $5.3 billion in cash and roughly $2.3 billion in stock for Bayer's animal-health unit.
Write to Colin Kellaher at colin.kellaher@wsj.com
(END) Dow Jones Newswires
January 23, 2020 06:37 ET (11:37 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
1 Year Bayer Aktiengesellschaft (PK) Chart |
1 Month Bayer Aktiengesellschaft (PK) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
